Asparagus racemosus (Shatavarin IV)

Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Asparagus racemosus (Shatavarin IV).

Asparagus racemosus functions as a potent galactagogue and adaptogen by modulating the hypothalamic-pituitary-adrenal axis and exerting phytoestrogenic activity via steroidal saponins that competitively bind to estrogen receptors.

Verified Molecular Profiling (NIH PubChem)

PubChem CID

161485

Molecular Weight

720.7 g/mol

XLogP3 (Lipophilicity)

N/A

IUPAC Name

disodium;5-[[4-amino-6-(2-hydroxyethylamino)-1,3,5-triazin-2-yl]amino]-2-[2-[4-[[4-amino-6-(2-hydroxyethylamino)-1,3,5-triazin-2-yl]amino]-2-sulfonatophenyl]ethenyl]benzenesulfonate

Pharmacokinetic Synergies & Enhancers

Proven Synergy Pairings

Withania somnifera for enhanced adaptogenic HPA-axis regulation
Trigonella foenum-graecum for synergistic prolactin modulation in lactation support

Biological Formulation Enhancers

Piperine for inhibition of P-glycoprotein-mediated efflux of saponins
Quercetin for potential inhibition of phase II metabolism of steroidal components

Delivery System Constraints & Modeling

Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Asparagus racemosus (Shatavarin IV) across standard consumer modalities.

💊 Standard Capsules

The hygroscopic nature of concentrated Shatavari extracts requires moisture-resistant HPMC capsules to prevent clumping and maintain the stability of the saponin fraction.

🍬 Gummy & Pectin Formats

The high saponin content can lead to significant foaming during the pectin slurry preparation and may interfere with the cross-linking density of the gel matrix.

🔬 Thin-Film Oral Strips

The substantial therapeutic dose required for Shatavari extracts typically exceeds the 40-60mg payload limit of standard thin-film oral strips, complicating formulation of a single-strip dose.

For Brand Founders

Formulate with Asparagus racemosus (Shatavarin IV)

Ready to launch a product featuring Asparagus racemosus (Shatavarin IV)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.

Build Science-Backed Formulation

Efficacy Evidence

Maximize Asparagus racemosus (Shatavarin IV) Bioavailability

Need absolute proof that your Asparagus racemosus (Shatavarin IV) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.

Simulate Bioavailability

For R&D Labs & CDMOs

Asparagus racemosus (Shatavarin IV) Degradation Testing

Is your Asparagus racemosus (Shatavarin IV) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.

Model Active Degradation